DIA Biosimilars 2013

DKSH

DKSH, Bayer expand collaboration to Singapore

Monday, September 16, 2013 03:09 PM

DKSH Business Unit Healthcare, a market expansion services provider that partners with healthcare companies seeking to grow their business in Asia, is collaborating with Bayer Thai to provide services for Bayer's products in Singapore.

More... »

Cenduit: Now with Patient Reminders

GSK deal aims to grow business in Asia

Tuesday, May 14, 2013 01:30 PM

DKSH's Business Unit Healthcare, a market expansion services provider for healthcare companies seeking to grow their business in Asia, has signed an agreement with GlaxoSmithKline to provide contract sales services in both private clinics and trade channel for its antibiotic product line.

More... »

CRF Health – eCOA Forum

DKSH divests contract manufacturing plant OLIC to Fuji Pharma

Wednesday, August 8, 2012 10:47 AM

DKSH, a market expansion services provider with a focus on Asia, has agreed to divest OLIC, a contract manufacturing operation of pharmaceutical products in Thailand, to Fuji Pharma of Japan. The transaction is subject to customary closing conditions.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs